tiprankstipranks
Shandong Weigao Group Medical Polymer Co Ltd Class H (HK:1066)
:1066
Hong Kong Market
1066
Shandong Weigao Group Medical Polymer Co
RESEARCH TOOLSreports
Want to see HK:1066 full AI Analyst Report?

Shandong Weigao Group Medical Polymer Co (1066) Ratios

3 Followers

Shandong Weigao Group Medical Polymer Co Ratios

HK:1066's free cash flow for Q4 2025 was ¥0.43. For the 2025 fiscal year, HK:1066's free cash flow was decreased by ¥ and operating cash flow was ¥0.11. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 3.78 3.78 3.20 2.46 3.08
Quick Ratio
 3.32 3.32 2.78 2.13 2.69
Cash Ratio
 1.64 1.64 1.28 0.92 1.16
Solvency Ratio
 0.25 0.25 0.31 0.30 0.37
Operating Cash Flow Ratio
 0.48 0.47 0.46 0.37 0.37
Short-Term Operating Cash Flow Coverage
 1.89 1.85 2.32 1.10 2.30
Net Current Asset Value
¥ 10.44B¥ 10.44B¥ 10.02B¥ 8.96B¥ 8.54B
Leverage Ratios
Debt-to-Assets Ratio
 0.17 0.17 0.12 0.12 0.14
Debt-to-Equity Ratio
 0.25 0.25 0.18 0.19 0.21
Debt-to-Capital Ratio
 0.20 0.20 0.15 0.16 0.17
Long-Term Debt-to-Capital Ratio
 0.15 0.15 0.11 0.06 0.14
Financial Leverage Ratio
 1.50 1.50 1.46 1.50 1.53
Debt Service Coverage Ratio
 1.54 1.52 1.89 1.15 3.42
Interest Coverage Ratio
 7.40 7.35 9.56 7.48 15.28
Debt to Market Cap
 0.42 0.28 0.21 0.13 0.09
Interest Debt Per Share
 1.38 1.38 0.98 0.98 1.04
Net Debt to EBITDA
 -1.06 -1.08 -1.14 -0.79 -0.54
Profitability Margins
Gross Profit Margin
46.56%45.45%50.28%50.21%53.64%
EBIT Margin
14.13%14.05%17.37%19.97%26.27%
EBITDA Margin
21.31%21.38%24.01%26.86%32.16%
Operating Profit Margin
14.13%14.05%18.23%15.44%21.47%
Pretax Profit Margin
15.20%15.17%19.51%17.91%24.86%
Net Profit Margin
12.07%12.04%15.79%15.13%20.30%
Continuous Operations Profit Margin
12.80%12.78%16.53%15.58%21.66%
Net Income Per EBT
79.39%79.36%80.93%84.50%81.64%
EBT Per EBIT
107.57%108.03%107.02%115.99%115.77%
Return on Assets (ROA)
4.44%4.35%5.95%5.95%8.33%
Return on Equity (ROE)
6.64%6.51%8.70%8.92%12.76%
Return on Capital Employed (ROCE)
6.13%5.99%8.32%7.83%10.73%
Return on Invested Capital (ROIC)
4.94%4.83%6.75%6.20%8.96%
Return on Tangible Assets
5.12%5.02%6.98%7.00%9.93%
Earnings Yield
11.65%7.68%10.59%6.57%5.42%
Efficiency Ratios
Receivables Turnover
 1.60 1.57 1.76 2.22 2.37
Payables Turnover
 5.82 5.83 1.52 1.52 3.61
Inventory Turnover
 2.82 2.83 2.57 2.64 2.81
Fixed Asset Turnover
 1.76 1.73 1.85 1.89 1.86
Asset Turnover
 0.37 0.36 0.38 0.39 0.41
Working Capital Turnover Ratio
 0.88 0.91 1.07 1.13 1.16
Cash Conversion Cycle
 294.46 298.36 108.88 63.34 182.59
Days of Sales Outstanding
 227.77 231.86 207.93 164.44 153.71
Days of Inventory Outstanding
 129.45 129.09 141.84 138.29 129.90
Days of Payables Outstanding
 62.76 62.59 240.89 239.39 101.02
Operating Cycle
 357.22 360.95 349.77 302.72 283.61
Cash Flow Ratios
Operating Cash Flow Per Share
 0.58 0.56 0.61 0.62 0.49
Free Cash Flow Per Share
 0.20 0.38 0.48 0.46 0.24
CapEx Per Share
 0.38 0.18 0.13 0.15 0.25
Free Cash Flow to Operating Cash Flow
 0.34 0.67 0.79 0.75 0.50
Dividend Paid and CapEx Coverage Ratio
 1.51 1.37 1.90 1.97 1.19
Capital Expenditure Coverage Ratio
 1.51 3.06 4.68 4.08 1.98
Operating Cash Flow Coverage Ratio
 0.44 0.43 0.67 0.67 0.49
Operating Cash Flow to Sales Ratio
 0.20 0.20 0.21 0.21 0.16
Free Cash Flow Yield
6.49%8.40%11.23%6.94%2.15%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 8.58 13.02 9.45 15.22 18.45
Price-to-Sales (P/S) Ratio
 1.02 1.57 1.49 2.30 3.74
Price-to-Book (P/B) Ratio
 0.57 0.85 0.82 1.36 2.35
Price-to-Free Cash Flow (P/FCF) Ratio
 15.40 11.90 8.91 14.42 46.44
Price-to-Operating Cash Flow Ratio
 5.27 8.02 7.00 10.89 23.03
Price-to-Earnings Growth (PEG) Ratio
 -0.42 -0.54 2.08 -0.55 0.94
Price-to-Fair Value
 0.57 0.85 0.82 1.36 2.35
Enterprise Value Multiple
 3.74 6.26 5.07 7.78 11.10
Enterprise Value
 10.58B 17.45B 15.94B 27.65B 48.63B
EV to EBITDA
 3.74 6.26 5.07 7.78 11.10
EV to Sales
 0.80 1.34 1.22 2.09 3.57
EV to Free Cash Flow
 12.00 10.16 7.27 13.08 44.28
EV to Operating Cash Flow
 4.06 6.84 5.71 9.88 21.96
Tangible Book Value Per Share
 4.67 4.65 4.45 4.16 4.01
Shareholders’ Equity Per Share
 5.35 5.32 5.23 4.93 4.81
Tax and Other Ratios
Effective Tax Rate
 0.16 0.16 0.15 0.13 0.13
Revenue Per Share
 2.94 2.88 2.88 2.91 3.02
Net Income Per Share
 0.36 0.35 0.46 0.44 0.61
Tax Burden
 0.79 0.79 0.81 0.84 0.82
Interest Burden
 1.08 1.08 1.12 0.90 0.95
Research & Development to Revenue
 0.05 0.05 0.05 0.06 0.04
SG&A to Revenue
 0.28 0.27 0.28 0.09 0.08
Stock-Based Compensation to Revenue
 <0.01 <0.01 <0.01 <0.01 <0.01
Income Quality
 1.63 1.26 1.09 1.18 0.67
Currency in CNY